Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Breakfast taco and burrito recall elevated to high risk level by FDA

The breakfast foods were recalled due to the presence of foreign material

The Independent UK

Non-Invasive Chin Enhancements Are Booming—Here's What's Worth the Price Tag

These are the non-invasive treatments to know, according to leading plastic surgeons and dermatologists.

Marie Claire

From injectables to pills: how the new Wegovy tablet will change the weight loss market forever

IN FOCUS: The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky looks at how the landscape is changing

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Steve Cohen's Point72 Buys $20M of Biotech Stock Advancing Depression Treatment

Point72 Asset Management purchased over 1.2 million shares of Tonix Pharma at $16.28 each as the company aggressively advances its drug development programmes.

International Business Times UK

Photo: These Lenses Can Slow the Progression of Nearsightedness

While Europe and Asia have had Stellest glasses for years, the FDA finally approved them for the U.S. in 2025.

Reason

The FDA Just Snubbed Corcept Therapeutics. Should You Buy the Dip in CORT Stock or Stay Far Away

Corcept shares crash as the FDA rejects its application for relacorilant. But is it worth buying CORT stock on the pullback?

Barchart

FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026

Novo Nordisk is down big in 2025, but hope is far from lost in 2026. The company's newly approved weight-loss pill could be the remedy that shares need.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Stocks Settle Lower on Tech Weakness and Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.84%. March E-mini S&P futures (ESH26 ) fell -0.71%, and March E-mini Nasdaq futures...

Barchart

Is Seafood Becoming Less Safe to Eat?

If your feed makes it feel like seafood is riskier every month, you’re not alone. Between recalls, “do not eat” alerts, and scary headlines about bacteria, it’s easy to wonder if seafood becoming less safe is the new normal. The truth is that seafood is still a healthy, budget-friendly protein…

Grocery Coupon Guide

Food Safety Investigators Warn of Contaminated Produce Arriving Late in Season

Late-season shopping can feel like a bonus round: one more batch of berries, a surprise deal on greens, a “why not” bag of grapes. The catch is that late-season supply can travel farther, sit longer, and change sources without you noticing. That’s why warnings can pop up when everyone assumes…

Grocery Coupon Guide

Stocks Decline as Chip Makers and Data Storage Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.34%. March E-mini S&P futures (ESH26 ) are down -0.35%, and March E-mini Nasdaq futures...

Barchart

Stocks Slide on Weakness in Megacap Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.19%. March E-mini S&P futures (ESH26 ) are down -0.17%, and March E-mini Nasdaq futures...

Barchart

‘She has no expertise’: the US medical community girds for Tracy Beth Høeg’s tenure at the FDA

The Danish American who doubted Covid shots is meant to lead drug regulation – but has focused on vaccines

The Guardian - US

Rodent and bird feces prompt recall of snacks and supplements

The recalled products were sold at various retailers in three U.S. states

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Novo Nordisk's Future Vision on 'Weight Loss' Wins Scientists, Tests Wall Street's Patience

Novo Nordisk's long-term strategy for weight-loss treatments has earned praise from scientists, even as investors grow cautious about timelines, competition and near-term returns.

Grocery Coupon Guide

Food Safety Auditors Identify Lapses in Temperature Logs During Peak Hours

When you grab a pre-made sandwich or a rotisserie chicken from your local grocery store, you probably assume it’s been stored at a safe temperature. But recent food safety audits suggest that assumption might not always hold up—especially during the busiest times of day. Auditors have found that temperature logs,…

Fortune

Feel Free customers say the kratom drink is making them sick. Toothless FDA rules on dietary supplements are helping it remain a bestseller

Botanic Tonics’ supplement drinks have taken convenience stores by storm—even as the company has battled allegations of misleading labeling.

The Independent UK

People don’t know how much sugar they eat. ‘Healthy’ buzzwords don’t help

Eating excess sugar is linked to heart disease

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Dog treats recalled across seven US states over health risk

The treats were sold in four-pound bags

MarketBeat

Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026

Eli Lilly has been a huge winner in the last few months of 2025. New clinical data support its outlook in 2026, with large potential catalysts on the horizon.

Barchart

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Tom’s Guide

I gave my Dad audio smart glasses for Christmas — now he reaches for these instead of his hearing aid

My Dad fixed his mild hearing loss with this stylish breakthrough pair of smart glasses, and it may be the best looking over-the-counter hearing aid you can buy right now.

The Conversation

How testosterone went from prostate cancer villain to potential ally

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades.

Barchart

This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now?

Abbott’s latest regulatory progress supports its durable growth narrative. Is now the right time to revisit ABT shares?

The Independent UK

Tens of thousands of bags of frozen shrimp recalled over possible radioactive contamination

No illnesses linked to the recalled shrimp have been reported so far, the FDA said

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Dow Jones Industrials

316 stories

B’

284 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.